Diagnostics (Feb 2024)

Clinical Indicators of Bone Deterioration in Alcoholic Liver Cirrhosis and Chronic Alcohol Abuse: Looking beyond Bone Fracture Occurrence

  • Milos Stulic,
  • Jelena Jadzic,
  • Natasa Dostanic,
  • Milica Zivkovic,
  • Tihomir Stojkovic,
  • Jelena Aleksic,
  • Stefan Stojkovic,
  • Milica Stojkovic Lalosevic,
  • Marko Vojnovic,
  • Zeljko Vlaisavljevic,
  • Jelena Martinov Nestorov,
  • Tatjana Nikolić,
  • Violeta Culafic Vojinovic,
  • Djordje Culafic,
  • Danijela Djonic

DOI
https://doi.org/10.3390/diagnostics14050510
Journal volume & issue
Vol. 14, no. 5
p. 510

Abstract

Read online

Although previous studies indicated that chronic alcohol abuse (CAA) and alcoholic liver cirrhosis (ALC) are associated with increased bone fragility, understanding bone fragility determinants is still modest in these individuals. We used a comprehensive individualized clinical fracture risk assessment approach (vertebral osteodensitometry, femoral osteodensitometry and geometry, and serum bone turnover biomarkers) to compare adult male patients with ALC who have not previously had femoral or vertebral fractures (n = 39), patients with CAA (without liver cirrhosis, n = 78) who have not previously had femoral or vertebral fractures and healthy age- and sex-matched controls (n = 43). Our data suggested that intertrochanteric bone mineral density was significantly lower in ALC and CAA patients than in controls. Also, the trabecular bone score was considerably lower in ALC patients compared with CAA and control individuals. The most significant inter-group differences in femoral geometry were noted on the femoral shaft. Patients with ALC and CAA have a higher 10-year risk of major osteoporotic fractures compared to the controls. Analysis of bone turnover biomarkers showed increased osteoprotegerin and beta-C-terminal telopeptide serum concentrations and decreased insulin growth factor-1 concentrations in patients with ALC compared to CAA and control groups. Our data revealed that bone alterations are present in patients with ALC and CAA even if they did not sustain a nontraumatic bone fracture, but it is also indicative that current bone-assessing clinical methods are not entirely reliable. Thus, future studies should focus on developing a reliable integrative clinical tool that can be used to accurately predict and prevent bone fracture occurrences in patients with ALC and CAA.

Keywords